{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:38:30Z","timestamp":1791545910889,"version":"4.3.4"},"reference-count":80,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.clinthera.2011.01.005","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T09:06:24Z","timestamp":1298538384000},"page":"2282-2303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Contemporary Pharmacologic Treatments for Spasticity of the Upper Limb After Stroke: A Systematic Review"],"prefix":"10.1016","volume":"32","author":[{"given":"Eleanor L.","family":"Olvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Grizzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.01.005_bib1","first-page":"e46","article-title":"Heart disease and stroke statistics\u20142010 update: A report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2011.01.005_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/01.STR.28.2.284","article-title":"Stroke in a defined elderly population, 1967\u20131985","volume":"28","author":"Barker","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2011.01.005_bib3","first-page":"S1","article-title":"Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion","volume":"6","author":"Mayer","year":"1997","journal-title":"Muscle Nerve Suppl"},{"key":"10.1016\/j.clinthera.2011.01.005_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1468-1331.2008.02114.x","article-title":"Prevalence of disabling spasticity 1 year after first-ever stroke","volume":"15","author":"Lundstr\u00f6m","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinthera.2011.01.005_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1191\/0269215502cr512oa","article-title":"Prevalence of spasticity post stroke","volume":"16","author":"Watkins","year":"2002","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/01.STR.0000105386.05173.5E","article-title":"Spasticity after stroke: Its occurrence and association with motor impairments and activity limitations","volume":"35","author":"Sommerfeld","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2011.01.005_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00002018-200629010-00003","article-title":"Botulinum toxin treatment of adult spasticity: A benefit-risk assessment","volume":"29","author":"Sheean","year":"2006","journal-title":"Drug Safety"},{"issue":"Suppl 6","key":"10.1016\/j.clinthera.2011.01.005_bib8","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1097\/00002508-200211001-00011","article-title":"Treatment of spasticity with botulinum toxin","volume":"18","author":"O'Brien","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.clinthera.2011.01.005_bib9","first-page":"665","article-title":"Treatment of spasticity with botulinum toxin","volume":"6","author":"Baba","year":"2004","journal-title":"Ortop Traumatol Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib10","first-page":"27","article-title":"Falls and fractures in older post-stroke patients with spasticity: Consequences and drug treatment considerations","volume":"12","author":"Esquenazi","year":"2004","journal-title":"Clin Geriatr"},{"key":"10.1016\/j.clinthera.2011.01.005_bib14","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1161\/01.STR.0000180861.54180.FF","article-title":"Management of adult stroke rehabilitation care: A clinical practice guideline","volume":"36","author":"Duncan","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2011.01.005_bib15","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1212\/01.wnl.0000311391.00944.c4","article-title":"Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2011.01.005_bib17","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.clinthera.2011.01.005_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/1545968309341060","article-title":"Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: A randomized controlled study","volume":"24","author":"Sun","year":"2010","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.clinthera.2011.01.005_bib20","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1185\/03007995.2010.497103","article-title":"Botulinum toxin type A in post-stroke upper limb spasticity","volume":"26","author":"Kaji","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2011.01.005_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/09638280400009360","article-title":"The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity","volume":"27","author":"Suputtitada","year":"2005","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1191\/026921500666642221","article-title":"A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury","volume":"14","author":"Smith","year":"2000","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/jnnp.2006.103341","article-title":"Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: A randomised, double blind, placebo controlled study of botulinum toxin A","volume":"78","author":"Yelnik","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinthera.2011.01.005_bib24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2340\/16501977-0366","article-title":"Botulinum toxin A for treatment of upper limb spasticity following stroke: A multi-centre randomized placebo-controlled study of the effects on the quality of life and other person-centred outcomes","volume":"41","author":"McCrory","year":"2009","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.clinthera.2011.01.005_bib25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2340\/16501977-0066","article-title":"Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke?","volume":"39","author":"Marco","year":"2007","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.clinthera.2011.01.005_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0269215506072082","article-title":"A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity","volume":"21","author":"Kong","year":"2007","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1191\/026921598668275996","article-title":"Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: A randomized, double-blind, placebo-controlled trial","volume":"12","author":"Hesse","year":"1998","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib28","doi-asserted-by":"crossref","first-page":"9e2","DOI":"10.1016\/j.apmr.2008.04.030","article-title":"Botulinum toxin dilution and endplate targeting in spasticity: A double-blind controlled study","volume":"90","author":"Gracies","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2340\/16501977-0120","article-title":"Associated reactions after stroke: A randomized controlled trial of the effect of botulinum toxin type A","volume":"40","author":"Bhakta","year":"2008","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.clinthera.2011.01.005_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jnnp.69.2.217","article-title":"Impact of botulinum toxin type A on disability and career burden due to arm spasticity after stroke: A randomised double blind placebo controlled trial [published correction appears in J Neurol Neurosurg Psychiatry. 2001;70:821]","volume":"69","author":"Bhakta","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinthera.2011.01.005_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1468-1331.2001.00277.x","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke","volume":"8","author":"Bakheit","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinthera.2011.01.005_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.apmr.2003.08.077","article-title":"Botulinum toxin type B in upper-limb poststroke spasticity: A double-blind, placebo-controlled trial","volume":"85","author":"Brashear","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib33","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.apmr.2003.10.015","article-title":"Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke","volume":"85","author":"Childers","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib34","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.46.5.1306","article-title":"Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial","volume":"46","author":"Simpson","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2011.01.005_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002060-200205000-00007","article-title":"Botulinum toxin in upper limb spasticity after acquired brain injury: A randomized trial comparing dilution techniques","volume":"81","author":"Francisco","year":"2002","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke","volume":"347","author":"Brashear","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.01.005_bib37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/STROKEAHA.107.484048","article-title":"Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: A randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide","volume":"39","author":"Lim","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2011.01.005_bib38","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/jnnp.2008.159657","article-title":"Botulinum neurotoxin vs tizanidine in upper limb spasticity: A placebo-controlled study","volume":"80","author":"Simpson","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinthera.2011.01.005_bib39","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/01.STR.31.10.2402","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke","volume":"31","author":"Bakheit","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2011.01.005_bib40","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.apmr.2009.02.026","article-title":"A preliminary assessment of the benefits of the addition of botulinum toxin a to a conventional therapy program on the function of people with longstanding stroke","volume":"90","author":"Meythaler","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0269215509358945","article-title":"Does low-dose botulinum toxin help the recovery of arm function when given early after stroke?","volume":"24","author":"Cousins","year":"2010","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12325-008-0139-2","article-title":"Dynamic splinting after treatment with botulinum toxin type-A: A randomized controlled pilot study","volume":"26","author":"Lai","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.clinthera.2011.01.005_bib43","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.apmr.2005.03.019","article-title":"The use of a portable muscle tone measurement device to measure the effects of botulinum toxin type a on elbow flexor spasticity","volume":"86","author":"Chen","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib44","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1212\/01.WNL.0000144349.95487.91","article-title":"Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke","volume":"63","author":"Gordon","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2011.01.005_bib45","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/PHM.0b013e31813e2b4d","article-title":"Botulinum toxin a, evidence-based exercise therapy, and constraint-induced movement therapy for upper-limb hemiparesis attributable to stroke: A preliminary study","volume":"86","author":"Levy","year":"2007","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10072-005-0379-8","article-title":"Botulinum toxin type A for upper limb spasticity following stroke: An open-label study with individualised, flexible injection regimens","volume":"26","author":"Slawek","year":"2005","journal-title":"Neurol Sci"},{"key":"10.1016\/j.clinthera.2011.01.005_bib47","first-page":"265","article-title":"Change of stretch reflex threshold in spasticity: Effect of botulinum toxin injections","volume":"142","author":"Stampacchia","year":"2004","journal-title":"Arch Ital Biol"},{"key":"10.1016\/j.clinthera.2011.01.005_bib48","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.apmr.2006.08.323","article-title":"Intrathecal baclofen management of poststroke spastic hypertonia: Implications for function and quality of life","volume":"87","author":"Ivanhoe","year":"2006","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib49","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/hs0901.095682","article-title":"Intrathecal baclofen for spastic hypertonia from stroke","volume":"32","author":"Meythaler","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2011.01.005_bib50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00002060-200007000-00010","article-title":"Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb","volume":"79","author":"Lagalla","year":"2000","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/PL00007851","article-title":"Efficacy of botulinum toxin A in upper limb function of hemiplegic patients","volume":"249","author":"Rousseaux","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.clinthera.2011.01.005_bib52","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00002060-200204000-00005","article-title":"Effect of intramuscular botulinum toxin injection on upper limb spasticity in stroke patients","volume":"81","author":"Wang","year":"2002","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib53","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1191\/0269215502cr536oa","article-title":"Are we underestimating the clinical efficacy of botulinum toxin (type A)?","volume":"16","author":"Pandyan","year":"2002","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/154596839601000107","article-title":"Disability changes after treatment of upper limb spasticity with botulinum toxin","volume":"10","author":"Reiter","year":"1996","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.clinthera.2011.01.005_bib55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00002060-200001000-00010","article-title":"Botulinum toxin injection of spastic finger flexors in hemiplegic patients","volume":"79","author":"Rodriquez","year":"2000","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/apmr.2003.50070","article-title":"Treatment with botulinum toxin type B for upper-limb spasticity","volume":"84","author":"Brashear","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/026921559701100102","article-title":"Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients","volume":"11","author":"Sampaio","year":"1997","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib58","first-page":"413","article-title":"Botulinum treatment for post-stroke spasticity: Low dose regime","volume":"81","author":"Viriyavejakul","year":"1998","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.clinthera.2011.01.005_bib59","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1097\/00001756-199709290-00008","article-title":"Botulinum toxin in upper limb spasticity: Study of reciprocal inhibition between forearm muscles","volume":"8","author":"Girlanda","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.clinthera.2011.01.005_bib60","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/01.STR.32.8.1841","article-title":"Open-label dose-titration safety and efficacy study of tizanidine hydrochloride in the treatment of spasticity associated with chronic stroke","volume":"32","author":"Gelber","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2011.01.005_bib61","first-page":"147","article-title":"Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX)","volume":"15","author":"Panizza","year":"2000","journal-title":"Funct Neurol"},{"key":"10.1016\/j.clinthera.2011.01.005_bib62","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.apmr.2008.01.007","article-title":"Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients","volume":"89","author":"Elovic","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib63","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/jnnp.61.1.30","article-title":"Use of botulinum toxin in stroke patients with severe upper limb spasticity","volume":"61","author":"Bhakta","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinthera.2011.01.005_bib64","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/STROKEAHA.108.544346","article-title":"Effect of upper limb botulinum toxin injections on impairment, activity, participation, and quality of life among stroke patients","volume":"40","author":"Caty","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2011.01.005_bib65","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00415-004-0297-3","article-title":"Botulinum toxin in post-stroke patients: Stiffness modifications and clinical implications","volume":"251","author":"Miscio","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.clinthera.2011.01.005_bib66","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000073058","article-title":"Is the reduction of spasticity by botulinum toxin a beneficial for the recovery of motor function of arm and hand in stroke patients?","volume":"50","author":"Woldag","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1016\/j.clinthera.2011.01.005_bib67","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/09638280801906388","article-title":"Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: A preliminary analysis of goals and outcomes","volume":"31","author":"Ashford","year":"2009","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib68","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/jnnp.2003.035139","article-title":"The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles","volume":"75","author":"Bakheit","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinthera.2011.01.005_bib69","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1590\/S0004-282X2007000400008","article-title":"Does botulinum toxin improve the function of the patient with spasticity after stroke?","volume":"65","author":"Cardoso","year":"2007","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.clinthera.2011.01.005_bib70","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.apmr.2009.03.008","article-title":"Effect of baseline spastic hemiparesis on recovery of upper-limb function following botulinum toxin type A injections and postinjection therapy","volume":"90","author":"Chang","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14260","article-title":"BoTULS: A multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A","volume":"14","author":"Shaw","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.clinthera.2011.01.005_bib72","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/1545968309347682","article-title":"Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: Analysis of function and kinematics of reaching movements","volume":"24","author":"Bensmail","year":"2010","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.clinthera.2011.01.005_bib73","first-page":"540","article-title":"Preliminary trial of carisoprodol in multiple sclerosis","volume":"192","author":"Ashworth","year":"1964","journal-title":"Practitioner"},{"key":"10.1016\/j.clinthera.2011.01.005_bib74","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of a modified Ashworth scale of muscle spasticity","volume":"67","author":"Bohannon","year":"1987","journal-title":"Phys Ther"},{"key":"10.1016\/j.clinthera.2011.01.005_bib75","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1136\/jnnp.2003.025551","article-title":"Does reducing spasticity translate into functional benefit?","volume":"75","author":"Francis","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinthera.2011.01.005_bib76","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/S0004-282X2005000100006","article-title":"Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: A meta-analysis","volume":"63","author":"Cardoso","year":"2005","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.clinthera.2011.01.005_bib77","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.apmr.2006.02.015","article-title":"Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity","volume":"87","author":"Turkel","year":"2006","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2011.01.005_bib78","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.clinthera.2007.04.015","article-title":"Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: A pooled-data analysis of three clinical trials","volume":"29","author":"Yablon","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.01.005_bib79","first-page":"666","article-title":"Consensus statement on the use of botulinum neurotoxin to treat spasticity in adults","volume":"31","author":"Davis","year":"2006","journal-title":"P&T"},{"key":"10.1016\/j.clinthera.2011.01.005_bib80","series-title":"Botulinum toxin A in the treatment of upper and lower limb spasticity: A systematic review of randomized controlled trials [Technology overview no 18]","author":"Garces","year":"2006"},{"key":"10.1016\/j.clinthera.2011.01.005_bib81","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/165019702753557836","article-title":"Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: A systematic review of the literature","volume":"34","author":"van Kuijk","year":"2002","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.clinthera.2011.01.005_bib82","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/mds.22452","article-title":"Botulinum neurotoxins for post-stroke spasticity in adults: A systematic review","volume":"24","author":"Elia","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2011.01.005_bib83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2340\/16501977-0303","article-title":"European consensus table on the use of botulinum toxin type A in adult spasticity","volume":"41","author":"Wissel","year":"2009","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.clinthera.2011.01.005_bib84","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/01.WNL.0000141863.52691.44","article-title":"Oral antispastic drugs in nonprogressive neurologic diseases: A systematic review","volume":"63","author":"Montan\u00e9","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2011.01.005_bib85","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpainsymman.2004.05.002","article-title":"Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: A systematic review","volume":"28","author":"Chou","year":"2004","journal-title":"J Pain Symptom Manage"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811000063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811000063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:48:23Z","timestamp":1758962903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811000063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":80,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0149291811000063"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.01.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary Pharmacologic Treatments for Spasticity of the Upper Limb After Stroke: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}